XML 21 R6.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Deficit
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Dec. 26, 2022   29,932,668      
Balance at beginning of period at Dec. 26, 2022 $ (390,861) $ 300 $ 2,797 $ (393,321) $ (637)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 70,175     70,175  
Shares issued under stock plans (in shares)   65,779      
Shares issued under stock plans 951   951    
Tax payments for restricted stock upon vesting (in shares)   (14,575)      
Tax payments for restricted stock upon vesting (2,480)     (2,480)  
Stock-based compensation expense 15,558   15,558    
Dividends declared on common stock and equivalents $ (24,729)   (16,239) (8,490)  
Purchases of common stock (in shares) (645,952) (645,952)      
Purchases of common stock $ (126,276) $ (7) (391) (125,878)  
Currency translation adjustment 296       296
Balance at end of period (in shares) at Dec. 30, 2023   29,337,920      
Balance at end of period at Dec. 30, 2023 (457,366) $ 293 2,676 (459,994) (341)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 108,717     108,717  
Shares issued under stock plans (in shares)   58,234      
Shares issued under stock plans 1,557 $ 1 1,556    
Tax payments for restricted stock upon vesting (in shares)   (12,736)      
Tax payments for restricted stock upon vesting (4,427)     (4,427)  
Stock-based compensation expense 22,060   22,060    
Dividends declared on common stock and equivalents $ (28,900)   (11,524) (17,376)  
Purchases of common stock (in shares) (720,804) (720,804)      
Purchases of common stock $ (317,067) $ (7) (13,200) (303,860)  
Currency translation adjustment $ (160)       (160)
Balance at end of period (in shares) at Dec. 28, 2024 28,662,614 28,662,614      
Balance at end of period at Dec. 28, 2024 $ (675,586) $ 287 1,568 (676,940) (501)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 174,267     174,267  
Shares issued under stock plans (in shares)   144,418      
Shares issued under stock plans 1,367   1,367    
Tax payments for restricted stock upon vesting (in shares)   (48,020)      
Tax payments for restricted stock upon vesting (13,854)     (13,854)  
Stock-based compensation expense 24,878   24,878    
Dividends declared on common stock and equivalents $ (32,235)   (13,505) (18,730)  
Purchases of common stock (in shares) (1,218,393) (1,218,393)      
Purchases of common stock $ (222,449) $ (12) (12,779) (209,658)  
Currency translation adjustment $ 6,850       6,850
Balance at end of period (in shares) at Dec. 27, 2025 27,540,619 27,540,619      
Balance at end of period at Dec. 27, 2025 $ (736,762) $ 275 $ 1,529 $ (744,915) $ 6,349